What does it mean to suddenly receive a text message saying that there is no invasion after the insurance takes effect for half a month?

Isn't it necessary to send an insurance to do non-invasive, or that insurance will take effect.

Non-invasive prenatal DNA testing is also called non-invasive prenatal DNA testing and non-invasive fetal chromosome aneuploidy testing. According to the Committee of American College of Obstetrics and Gynecology, an international authoritative academic organization, non-invasive prenatal examination is the most widely used technical name. ?

Non-invasive DNA prenatal detection technology only needs to extract the venous blood of pregnant women, and use the new generation DNA sequencing technology to sequence the free DNA fragments (including fetal free DNA) in pregnant women's peripheral plasma, and analyze the biological information of the sequencing results to obtain the genetic information of the fetus, so as to detect whether the fetus has three major chromosome diseases.

Medical institutions that expand information to carry out prenatal screening and diagnosis of fetal free DNA in peripheral blood of pregnant women shall obtain the Practice License for Maternal and Child Health Care Technical Services.

Medical institutions that carry out prenatal screening and diagnosis of fetal free DNA in peripheral blood of pregnant women (hereinafter referred to as blood collection and supply institutions) should be qualified prenatal screening or prenatal diagnosis institutions. Prenatal screening institutions that carry out blood collection services must establish cooperative relations with prenatal diagnosis institutions and file with provincial health and family planning administrative departments.

Medical institutions (hereinafter referred to as testing institutions) that carry out laboratory testing of fetal free DNA in maternal peripheral blood shall have the qualifications of clinical gene amplification laboratories, strictly abide by the relevant provisions such as the Measures for the Administration of Clinical Laboratories in Medical Institutions and the Measures for the Administration of Clinical Gene Amplification Laboratories in Medical Institutions, and the corresponding testing items shall be evaluated by the Clinical Testing Center of the National Health and Family Planning Commission.

Baidu Encyclopedia-Noninvasive DNA Prenatal Detection Technology